HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazuya Shimura Selected Research

Kazuya Shimura Research Topics

Disease

11Infections
01/2021 - 01/2008
2HIV Infections (HIV Infection)
12/2019 - 10/2009
2Virus Diseases (Viral Diseases)
11/2012 - 09/2012
1COVID-19
01/2021

Drug/Important Bio-Agent (IBA)

4Antiviral Agents (Antivirals)IBA
10/2015 - 01/2008
46H- 6- imino- (2,3,4,5- tetrahydropyrimido)(1,2- c)- (1,3)benzothiazineIBA
04/2015 - 09/2012
3IminesIBA
04/2015 - 11/2012
2Anti-Retroviral Agents (Antiretroviral Agents)IBA
04/2015 - 11/2012
2pyrimidineIBA
04/2015 - 04/2015
1Neutralizing AntibodiesIBA
01/2021
1AntibodiesIBA
01/2021
1Monoclonal AntibodiesIBA
01/2021
1Immunoglobulin G (IgG)IBA
01/2021
1Messenger RNA (mRNA)IBA
01/2021
1CC ChemokinesIBA
01/2021
1Single-Chain AntibodiesIBA
12/2019
1EpitopesIBA
12/2019
1Anti-HIV Agents (AIDS Drugs)IBA
10/2015
1Raltegravir PotassiumFDA Link
04/2013
1HIV Reverse TranscriptaseIBA
04/2013
1Tenofovir (Viread)FDA Link
04/2013
1Zidovudine (Retrovir)FDA LinkGeneric
04/2013
1HIV IntegraseIBA
04/2013
15-dimethylamilorideIBA
11/2012
1Peptides (Polypeptides)IBA
12/2010
1Enfuvirtide (Fuzeon)FDA Link
12/2010
1EnzymesIBA
01/2008
1elvitegravirIBA
01/2008
1L870810IBA
01/2008
1Pharmaceutical PreparationsIBA
01/2008

Therapy/Procedure

1Therapeutics
09/2016